Streptococcus agalactiae or group B streptococcus (GBS) is a leading cause of serious
neonatal infections. GBS is an opportunistic commensal constituting a part of the intestinal …

Group B streptococcus (GBS) causes a high burden of neonatal and infant disease globally.
Implementing a vaccine for pregnant women is a promising strategy to prevent neonatal and …

Diabetic wounds have poor healing outcomes due to the presence of numerous pathogens
and a dysregulated immune response. Group B Streptococcus (GBS) is commonly isolated …

Microbial natural products comprise diverse architectures that are generated by equally
diverse biosynthetic strategies. In peptide natural products, amino acid sidechains are …

Background Streptococcus agalactiae or group B Streptococcus (GBS) has emerged as an
important cause of invasive disease in adults, particularly among the elderly and those with …

Background. Streptococcus agalactiae (group B Streptococcus [GBS]) has not been
described as a foodborne pathogen. However, in 2015, a large outbreak of severe invasive …

Abstract Globally, group B Streptococcus (GBS) remains the leading cause of sepsis and
meningitis in young infants, with its greatest burden in the first 90 days of life. Intrapartum …

Streptococcus agalactiae (group B streptococcus, GBS) is a leading causal organism of
neonatal invasive diseases and severe infections in the elderly. Despite significant …

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is a bacteria with
truly protean biology. It infects a variety of hosts, among which the most commonly studied …

Streptococcus agalactiae (group B streptococcus; GBS) is a colonizer of the gastrointestinal
and urogenital tracts, and an opportunistic pathogen of infants and adults. The worldwide …